V

Veracyte
D

VCYT

30.335
USD
0.64
(2.14%)
مغلق
حجم التداول
102,485
الربح لكل سهم
1
العائد الربحي
-
P/E
98
حجم السوق
2,375,658,800
أصول ذات صلة
A
ADPT
2.49500
(34.04%)
9.82500 USD
BMRN
BMRN
-0.700
(-1.12%)
61.980 USD
DXCM
DXCM
11.350
(16.17%)
81.560 USD
F
FATE
0.09000
(7.38%)
1.31000 USD
REGN
REGN
15.98
(2.71%)
606.12 USD
R
RGEN
4.530
(3.30%)
141.720 USD
T
TDOC
0.09000
(1.29%)
7.06500 USD
VEEV
VEEV
4.350
(1.88%)
236.310 USD
المزيد
الأخبار المقالات

العنوان: Veracyte

القطاع: Healthcare
الصناعة: Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.